as on November 6, 2025 at 2:29 am IST
Day's Low
Day's High
5.45%
Downside
26.36%
Upside
52 Week's Low
52 Week's High
3.64%
Downside
695.45%
Upside
Check Redhill Biopharma Ltd-sp Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.2M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-8.3M
Revenue (TTM)
9.6M
Profit Margin
-97.52%
Return On Equity TTM
-1708.61%
Compare market cap, revenue, PE, and other key metrics of Redhill Biopharma Ltd-sp Adr with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.2M | -99.99% | NA | -97.52% | |
| BUY | $18.8B | NA | 16.59 | 40.65% | |
| BUY | $41.8B | NA | 21.32 | 13.81% | |
| BUY | $14.2B | 42.73% | 33.88 | 15.95% | |
| BUY | $64.0B | -27.17% | 24.89 | 27.83% |
The Redhill Biopharma Ltd-sp Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Redhill Biopharma Ltd-sp Adr investment value today
Current value as on today
₹18,415
Returns
Returns from Redhill Biopharma Ltd-sp Adr Stock
Dollar Returns*
₹5,351 (+5.35%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Redhill Biopharma Ltd-sp Adr. Average target price of $19000
Get share price movements and forecasts by analysts on Redhill Biopharma Ltd-sp Adr.
What analysts predicted
99.99%UPSIDE
Target Price
$19000
Current Price
$1.1
Analyzed by
7 Analysts
Target
$19000.00
Redhill Biopharma Ltd-sp Adr target price $19000, a slight upside of 99.99% compared to current price of $1.1. According to 7 analysts rating.
Search interest for Redhill Biopharma Ltd-sp Adr Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:10% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -2.59M → -2.06M (in $), with an average increase of 12.7% per quarter
Against Peers
![]()
In the last 3 years, United Therapeutics Corporation has given 17.5% return, outperforming this stock by 117.3%
Against Peers
![]()
In the last 1 year, Neurocrine Biosciences Inc. has given 17.8% return, outperforming this stock by 104.7%
Price Dip
![]()
In the last 7 days, RDHL stock has moved down by -24.7%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 2.73M → 2.03M (in $), with an average decrease of 12.7% per quarter
| Organisation | Redhill Biopharma Ltd-sp Adr |
| Headquarters | 21 Ha?arba?a Street, Tel Aviv, Israel, 6473921 |
| Industry | Health Technology |
| CEO | Mr. Dror Ben-Asher |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Razi Ingber | Chief Financial Officer |
Mr. Adi Frish | Chief Corporate & Business Development Officer |
Mr. Rick D. Scruggs | Chief Commercial Officer & Director |
Mr. Gilead Raday MPhil, MSc | Chief Operating Officer |
Dr. Mark L. Levitt M.D., Ph.D. | Chief Scientific Officer |
Ms. Alexandra Okmian | Senior Business Development & Investor Relations Manager |
Dr. Reza Fathi Ph.D. | Senior Vice President of Research & Development |
Mr. Dror Ben-Asher | Co-Founder, Chairman & CEO |
Ms. Patricia Anderson B.Sc. RAC | Senior Vice President of Regulatory Affairs |
Mr. Guy Goldberg J.D. | Chief Business Officer |
Redhill Biopharma Ltd-sp Adr share price today is $1.1 as on at the close of the market. Redhill Biopharma Ltd-sp Adr share today touched a day high of $1.39 and a low of $1.04.
Redhill Biopharma Ltd-sp Adr share touched a 52 week high of $8.75 on and a 52 week low of $1.06 on . Redhill Biopharma Ltd-sp Adr stock price today i.e. is closed at $1.1,which is 87.43% down from its 52 week high and 3.77% up from its 52 week low.
Redhill Biopharma Ltd-sp Adr market capitalisation is $0.00T as on .
Indian investors can start investing in Redhill Biopharma Ltd-sp Adr (RDHL) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Redhill Biopharma Ltd-sp Adr stock (as per the Rupee-Dollar exchange rate as on ).
Based on Redhill Biopharma Ltd-sp Adr share’s latest price of $1.1 as on November 6, 2025 at 2:29 am IST, you will get 9.0909 shares of Redhill Biopharma Ltd-sp Adr. Learn more about
fractional shares .
Redhill Biopharma Ltd-sp Adr stock has given -99.99% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?